MBS659451 | MTG8 (CDR, ETO) Control Peptide (KLH)

MTG8 (CDR, ETO) Control Peptide (KLH) | MBS659451 | MyBiosource

Product Short Name: [MTG8]

Product Name Synonyme: [MTG8 (CDR, ETO) Control Peptide (KLH)]

Other Names: [MTG8; Protein CBFA2T1; protein CBFA2T1; eight twenty one protein; myeloid translocation gene on 8q22; zinc finger MYND domain-containing protein 2; acute myelogenous leukemia 1 translocation 1, cyclin-D related; core-binding factor, runt domain, alpha subunit 2; translocated to, 1; cyclin D-related; runt-related transcription factor 1; translocated to, 1 (cyclin D-related); Cyclin-D-related protein; Eight twenty one protein; Protein ETO; Protein MTG8; Zinc finger MYND domain-containing protein 2]

Product Gene Name: N/A

Product Gene Name Synonyme: N/A

Other Gene Names: [RUNX1T1; RUNX1T1; CDR; ETO; MTG8; AML1T1; ZMYND2; CBFA2T1; AML1T1; CBFA2T1; CDR; ETO; MTG8; ZMYND2]

Clonality: N/A

Isotype: N/A

Clone: N/A

Host: N/A

Reactivity: Human, Rodent

Specificity: Recognizes MTG8. Species Crossreactivity: Human and rodent.

Purity: Highly Purified
Highly purified (HPLC, MS)

Form: Supplied as a liquid in PBS. No preservative added. Conjugated with KLH.

Concentration: N/A

Storage Stability: Lyophilized powder may be stored at 4 degree C for short-term only. Stable for 12 months at -20 degree C. Reconstitute to nominal volume (see reconstitution instructions for peptides) and store at -20 degree C. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made in assay buffer.


Tested Application: Western Blot (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC)